Data as of 3:58pm ET
| +0.29 / +1.10%|
The 8 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 27.00, with a high estimate of 33.00 and a low estimate of 19.00. The median estimate represents a +1.50% increase from the last price of 26.60.
The current consensus among 8 polled investment analysts is to Hold stock in PharMerica Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.